← Search

Ola Engkvist

4 accepted papers

2026

FlexiFlow: decomposable flow matching for generation of flexible molecular ensemble

ICML 2026poster

Sampling useful three-dimensional molecular structures along with their most favorable conformations is a key challenge in drug discovery. Current state-of-the-art 3D de-novo design flow matching or diffusion-based models are limited to generating a single conformation. However, the conformational l…

Cited by 0SourceScholar
2025

Boltzmann priors for Implicit Transfer Operators

ICLR 2025poster

Accurate prediction of thermodynamic properties is essential in drug discovery and materials science. Molecular dynamics (MD) simulations provide a principled approach to this task, yet they typically rely on prohibitively long sequential simulations. Implicit Transfer Operator (ITO) Learning offers…

2025

Diversity-Aware Reinforcement Learning for de novo Drug Design

IJCAI 2025

Fine-tuning a pre-trained generative model has demonstrated good performance in generating promising drug molecules. The fine-tuning task is often formulated as a reinforcement learning problem, where previous methods efficiently learn to optimize a reward function to generate potential drug molecul

Cited by 0SourcePDFScholar
2023

Industry-Scale Orchestrated Federated Learning for Drug Discovery

AAAI 2023technical

To apply federated learning to drug discovery we developed a novel platform in the context of European Innovative Medicines Initiative (IMI) project MELLODDY (grant n°831472), which was comprised of 10 pharmaceutical companies, academic research labs, large industrial companies and startups. The MEL…

Cited by 48SourcePDFScholar